Targeting c-Kit mutations: basic science to novel therapies.
about
Acute Myeloid Leukemia: A Concise ReviewSpecification and function of hemogenic endothelium during embryogenesisNovel Prognostic and Therapeutic Mutations in Acute Myeloid LeukemiaHuntingtin-interacting protein 1: a Merkel cell carcinoma marker that interacts with c-Kit.Detection of c-kit mutational status in small-cell lung cancer in a Chinese cohort.Oncogenic KIT mutations in different exons lead to specific changes in melanocyte phospho-proteome.Heterozygous kit mutants with little or no apparent anemia exhibit large defects in overall hematopoietic stem cell functionMiR-34a-5p promotes the multi-drug resistance of osteosarcoma by targeting the CD117 gene.Changing pathology with changing drugs: skin cancer.Regulation of endothelial cell differentiation and specificationImatinib enhances human melanoma cell susceptibility to TRAIL-induced cell death: Relationship to Bcl-2 family and caspase activation.c-Kit mediates chemoresistance and tumor-initiating capacity of ovarian cancer cells through activation of Wnt/β-catenin-ATP-binding cassette G2 signaling.Acute myeloid leukaemia genomics.Inhibition of HMC-1 mast cell proliferation by vitamin E: involvement of the protein kinase B pathway.KIT polymorphisms were associated with the risk for head and neck squamous carcinoma in Chinese population.Putative DNA quadruplex formation within the human c-kit oncogene.Selective RNAi-mediated inhibition of mutated c-kit.The study of CD117 expression in glial tumors and its relationship with the tumor-type and grade.Observed versus predicted structure of fluorescent self-quenching reporter molecules (SQRM): caveats with respect to the use of "stem-loop" oligonucleotides as probes for mRNA folding.The role of stem cell factor and c-KIT in keloid pathogenesis: do tyrosine kinase inhibitors have a potential therapeutic role?A platinum(II) phenylphenanthroimidazole with an extended side-chain exhibits slow dissociation from a c-Kit G-quadruplex motif.Mapping normal and cancer cell signalling networks: towards single-cell proteomics.Childhood papillary thyroid cancer as second malignancy after successful treatment of rhabdomyosarcoma.Lymphoblastic leukemia/lymphoma in mice overexpressing the Mer (MerTK) receptor tyrosine kinase.
P2860
Q26766719-48CE758D-D85D-496A-8FEE-267742B96276Q26768587-FC84B571-0AAC-4477-BF9D-D01A6DD8598BQ28075654-8045713F-0852-4306-9D40-2EE8989867A8Q35216141-8552D431-697C-482F-A4DB-BD8D459E1D28Q36439341-0CEFD63E-A4F2-4F7B-8D78-9C900A8D207FQ37262426-F9620AFC-6F4B-4AE3-9349-ABDA9F6A5EA2Q37280159-72E1D31D-E496-4ABD-B2DC-4E31429D3DECQ37317570-20BC6D3D-8389-4999-84CE-14D5223E96C1Q37890206-828ADE5F-9955-439E-8A74-B6433039A2A7Q38101895-7BC0194A-0BAB-4559-B760-4DADC58C4ED0Q38309479-52ACC566-DE3C-463C-AE30-DB111B905651Q39314503-2E94AEBA-A6FB-4175-B57D-9386BC14F7C7Q39400164-ADE81529-0F23-4EA0-AF6C-CFCD1FA347ABQ40512385-4F04507A-BAD2-4948-B793-67954D0963AAQ40751221-C0FE2F11-ED09-4CCA-BFCC-BFC249F79E1EQ41774419-409D8928-01D0-43AC-9493-B824A56F89D1Q41836202-D564592F-AA71-49E9-83F5-195FDD742B39Q42416017-CEFA68D7-CCB4-48A6-BDAA-185CC78DFAD0Q43082328-00BCFD39-2920-45C9-83A5-52DA5C75F46BQ43436232-D13A595F-AC40-4679-ACA3-D67AF2F21E8CQ44100780-F6560652-5E94-4BD0-A5BB-24FB622F2510Q46307051-4B562A24-4264-4F40-985E-80CA51E6C386Q46695782-A20C4186-B7DF-4A3E-B0DD-97DBD9DE75D9Q47602968-4C9102A4-9D87-4AB0-B3E4-BDD771344780
P2860
Targeting c-Kit mutations: basic science to novel therapies.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Targeting c-Kit mutations: basic science to novel therapies.
@ast
Targeting c-Kit mutations: basic science to novel therapies.
@en
type
label
Targeting c-Kit mutations: basic science to novel therapies.
@ast
Targeting c-Kit mutations: basic science to novel therapies.
@en
prefLabel
Targeting c-Kit mutations: basic science to novel therapies.
@ast
Targeting c-Kit mutations: basic science to novel therapies.
@en
P1433
P1476
Targeting c-Kit mutations: basic science to novel therapies.
@en
P2093
Martin Sattler
P304
P356
10.1016/J.LEUKRES.2003.10.004
P478
28 Suppl 1
P50
P577
2004-05-01T00:00:00Z